Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 3,489	$ 2,955
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	(285)	306
Inventories and other assets	(68)	(301)
Accounts payable and accrued expenses	(459)	(505)
Depreciation and amortization	1,614	1,519
Income taxes	(4)	3
Losses (gains) on sales of facilities	(213)	14
Amortization of debt issuance costs and discounts	17	17
Share-based compensation	199	133
Other	150	137
Net cash provided by operating activities	4,440	4,278
Cash flows from investing activities:
Purchase of property and equipment	(2,399)	(2,438)
Acquisition of hospitals and health care entities	(131)	(124)
Sales of hospitals and health care entities	311	172
Change in investments	(14)	(16)
Other	(2)	(2)
Net cash used in investing activities	(2,235)	(2,408)
Cash flows from financing activities:
Issuance of long-term debt	4,483	3,218
Net change in revolving credit facilities	(1,030)	(1,840)
Repayment of long-term debt	(2,269)	(608)
Distributions to noncontrolling interests	(338)	(342)
Payment of debt issuance costs	(40)	(30)
Payment of dividends	(356)	(339)
Repurchase of common stock	(2,547)	(1,761)
Other	(212)	(221)
Net cash used in financing activities	(2,309)	(1,923)
Effect of exchange rate changes on cash and cash equivalents	0	7
Change in cash and cash equivalents	(104)	(46)
Cash and cash equivalents at beginning of period	935	908
Cash and cash equivalents at end of period	831	862
Interest payments	943	925
Income tax payments, net	$ 999	$ 773